Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
DKF-340 by Dongkook Pharmaceutical for Inflammation: Likelihood of Approval
DKF-340 is under clinical development by Dongkook Pharmaceutical and currently in Phase I for Inflammation. According to GlobalData, Phase I...